Inventor · disambiguated record
David Thomas Parker
Also filed as: PARKER DAVID T · PARKER DAVID THOMAS
18 granted patents·8 pending applications·682 citations·filing 1993–2020
95Inventor score
Top patents by PatentIndex Score
26 records- 0196US5552419AArylsulfonamido-substituted hydroxamic acidsCIBA GEIGY CORP·Filed 1994·Granted Sep 3, 1996·122 cites·17 claims
- 0295US8673848B2Synthetic apelin mimetics for the treatment of heart failureZECRI FREDERIC·Filed 2013·Granted Mar 18, 2014·53 cites·27 claims
- 0393US5455258AArylsulfonamido-substituted hydroxamic acidsCIBA GEIGY CORP·Filed 1993·Granted Oct 3, 1995·154 cites·15 claims
- 0491US5506242AArylsufonamido-substituted hydroxamic acidsCIBA GEIGY CORP·Filed 1994·Granted Apr 9, 1996·118 cites·17 claims
- 0590US5817822ACertain alpha-azacycloalkyl substituted arylsulfonamido acetohydroxamic acidsNOVARTIS AG·Filed 1997·Granted Oct 6, 1998·54 cites·20 claims
- 0688US8008263B2Organic compounds and their usesNOVARTIS AG·Filed 2008·Granted Aug 30, 2011·12 cites·17 claims
- 0785US8222425B2Organic compounds and their usesBRITT SHAWN D·Filed 2011·Granted Jul 17, 2012·12 cites·5 claims
- 0885US7825152B2Organic compounds and their usesNOVARTIS AG·Filed 2007·Granted Nov 2, 2010·7 cites·30 claims
- 0982US5672615AArylsulfonamido-substituted hydrodxamic acidsNOVARTIS AG·Filed 1996·Granted Sep 30, 1997·26 cites·14 claims
- 1081US5646167AArylsulfonamido-substituted hydroxamix acidsCIBA GEIGY CORP·Filed 1995·Granted Jul 8, 1997·63 cites·16 claims
- 1179US10844055B2Naphthyridinone derivatives and their use in the treatment of arrhythmiaNOVARTIS AG·Filed 2019·Granted Nov 24, 2020·1 cites·15 claims
- 1279US8211932B2Organic compounds and their usesPATANE MICHAEL·Filed 2010·Granted Jul 3, 2012·5 cites·15 claims
- 1378US8445527B2Organic compounds and their usesPATANE MICHAEL·Filed 2012·Granted May 21, 2013·4 cites·9 claims
- 1478US8372885B2Organic compounds and their usesNOVARTIS AG·Filed 2009·Granted Feb 12, 2013·4 cites·10 claims
- 1576US5770624ACertain alpha-substituted arylsulfonamido acetohydroxamic acidsNOVARTIS AG·Filed 1996·Granted Jun 23, 1998·40 cites·23 claims
- 1671US7202364B2Certain phenylacetic acids and derivativesNOVARTIS AG·Filed 2003·Granted Apr 10, 2007·7 cites·10 claims
- 1767US11530213B2Naphthyridinone derivatives and their use in the treatment of arrhythmiaNOVARTIS AG·Filed 2020·Granted Dec 20, 2022·0 cites·16 claims
- 1861US10266531B2Naphthyridinone derivatives and their use in the treatment of arrhythmiaNOVARTIS AG·Filed 2017·Granted Apr 23, 2019·0 cites·23 claims
- 1957US2013149281A1Organic compounds and their usesNOVARTIS AG·Filed 2013·Application pending·0 cites
- 2051US2007060569A1Azacycloalkyl substituted acetic acid derivatives for use as MMP inhibitorsFUJIMOTO ROGER A·Filed 2006·Application pending·0 cites
- 2147US2008045530A1Organic Compounds and Their UsesBRANDL TRIXI·Filed 2007·Application pending·0 cites
- 2246US2010204159A1Organic compounds and their usesBRANDL TRIXL·Filed 2007·Application pending·0 cites
- 2345US2004235896A1Certain azacycloalkyl substituted acetic acid derivativesFiled 2002·Application pending·0 cites
- 2444US2007265281A1Organic Compounds and Their UsesCOTTENS SYLVAIN·Filed 2007·Application pending·0 cites
- 2544US2010240638A1Organic Compounds and their usesBRITT SHAWN D·Filed 2008·Application pending·0 cites
- 2640US2016166634A1Bioconjugates of synthetic apelin polypeptidesCAPLAN SHARI LYNN·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when David Thomas Parker files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →